Autoantibody activity and V gene usage by B-cell malignancies.
Dighiero
G
G
Institute Pasteur, Paris, France.
D000818:Animals; D000831:Animals, Newborn / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000912:Antibodies, Neoplasm / Q000276:immunology*; D000918:Antibody Specificity; D015703:Antigens, CD; D001323:Autoantibodies / Q000096:biosynthesis* / Q000235:genetics; D001324:Autoantigens / Q000276:immunology; D018956:CD5 Antigens; D003429:Cross Reactions; D000939:Epitopes / Q000276:immunology; D005803:Genes, Immunoglobulin; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000235:genetics*; D015448:Leukemia, B-Cell / Q000235:genetics* / Q000276:immunology; D016393:Lymphoma, B-Cell / Q000235:genetics* / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008954:Models, Biological; D011110:Polymorphism, Genetic; D012217:Rheumatoid Factor / Q000276:immunology
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D015703:Antigens, CD; D001323:Autoantibodies; D001324:Autoantigens; D018956:CD5 Antigens; D000939:Epitopes; D007135:Immunoglobulin Variable Region; D012217:Rheumatoid Factor